Health ❯ Healthcare ❯ Cardiology

Cardiovascular Diseases

Myocardial Infarction Risk Factors Heart Failure Coronary Artery Disease Cardiovascular Events Heart Attack Risk Prediction Infectious Diseases Coronary Microvascular Dysfunction Cardiac Deaths Beta Blockers Antiplatelet Therapy Surgery Medications Hypertension Management Angina Statistics on Heart Diseases Heart Attacks Heart Attack Heart Conditions Impact of Pollution Heat Stress Clinical Trials Heart Centers Spontaneous Coronary Artery Dissection Polygenic Risk Scores Atherosclerosis Aortic Dissection Lipoprotein(a) Women's Health

Novartis' Pelacarsen Fails Phase 3 After Lowering Lp(a)

Investor confidence in the Lp(a) hypothesis has weakened; investors are reassessing rival programs and Novartis' late-stage pipeline.

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

Evolocumab Cuts First Cardiovascular Events by 31% in High‑Risk Diabetes Without Known Atherosclerosis

Study Finds Nearly All Heart Attacks, Strokes and Heart Failure Follow Earlier Risk Factors

Baxdrostat Lowers Blood Pressure in Hard-to-Treat Patients in Phase III Trial

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors